270 results on '"JONES, T. HUGH"'
Search Results
2. Diagnosis and Treatment of Testosterone Deficiency: Updated Recommendations From the Lisbon 2018 International Consultation for Sexual Medicine
3. Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind Randomised Controlled Trial
4. Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy
5. The British Society for Sexual Medicine Guidelines on Male Adult Testosterone Deficiency, with Statements for Practice
6. Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse
7. Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice
8. Glycaemic and metabolic effects of testosterone replacement in hypogonadal men with uncontrolled type 2 diabetes − a randomised double blinded placebo controlled trial − stride study
9. The effect of testosterone on quality of life, constitutional symptoms, sexual function and memory − randomised placebo-controlled study in hypogonadal men with uncontrolled type 2 diabetes − stride study
10. Effect of testosterone on body composition - randomised placebo-controlled study in hypogonadal men with uncontrolled type-2 diabetes - STRIDE STRUDY
11. Late Onset Hypogonadism
12. European Association of Urology Guidelines on Sexual and Reproductive Health—2021 Update: Male Sexual Dysfunction
13. Mechanisms of agonist-induced constriction in isolated human pulmonary arteries
14. Testosterone and Cardiovascular Risk in Men
15. Androgen Deficiency as a Predictor of Metabolic Syndrome in Aging Men: An Opportunity for Intervention?
16. Testosterone stimulates cholesterol clearance from human macrophages by activating LXRα
17. Testosterone Associations with Erectile Dysfunction, Diabetes, and the Metabolic Syndrome
18. Testosterone, obesity, diabetes and the metabolic syndrome
19. Intrinsic responses of rat coronary arteries in vitro: Influence of testosterone, calcium, and effective transmural pressure
20. Men with Low Testosterone and Type 2 Diabetes Have Reduced Health-Related Quality of Life (HRQoL)
21. Severity of Erectile Dysfunction and Testosterone Deficiency Are Associated with Reduced Quality of Life (HRQoL) in Men with Type 2 Diabetes Mellitus
22. Androgen Receptor CAG Repeat Polymorphism Modulates Change in Triglycerides, Diastolic Blood Pressure and PSA during Testosterone Replacement Therapy in Men with Metabolic Syndrome or Type 2 Diabetes – The TIMES2 Study
23. Tramadol-induced adrenal insufficiency
24. Introduction
25. Testosterone in Obesity, Metabolic Syndrome and Type 2 Diabetes
26. Testosterone in Chronic Heart Failure
27. Chapter 9 Puberty and fertility
28. Chapter 11 Obesity, metabolic syndrome, and diabetes
29. Testosterone and Coronary Artery Disease
30. Chapter 1 Testosterone deficiency: an overview
31. Chapter 12 The heart and cardiovascular disease
32. Chapter 3 Diagnosis of hypogonadism: symptoms, signs, tests, and guidelines
33. Chapter 2 Clinical physiology of testosterone
34. Response to Comment on: Jones et al. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study). Diabetes Care 2011;34: 828–837
35. Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes
36. Testosterone Replacement in Hypogonadal Men With Type 2 Diabetes and/or Metabolic Syndrome (the TIMES2 Study)
37. Low serum testosterone and increased mortality in men with coronary heart disease
38. Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes
39. Clinical and Biochemical Assessment of Hypogonadism in Men With Type 2 Diabetes: Correlations with bioavailable testosterone and visceral adiposity
40. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial
41. Replacement therapy, not recreational tonic
42. The Effect of Testosterone Replacement on Endogenous Inflammatory Cytokines and Lipid Profiles in Hypogonadal Men
43. Identification of Adrenocorticotropin Receptor Messenger Ribonucleic Acid in the Human Pituitary and Its Loss of Expression in Pituitary Adenomas
44. Low Levels of Endogenous Androgens Increase the Risk of Atherosclerosis in Elderly Men: Further Supportive Data
45. The release of leptin and its effect on hormone release from human pituitary adenomas
46. Mdm2 and the p53 pathway in human pituitary adenomas
47. Assessment and management of anti-insulin autoantibodies in varying presentations of insulin autoimmune syndrome
48. Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy
49. Male hypogonadism: 14‐year prospective outcome in 550 men with type 2 diabetes
50. Androgen Society Position Paper on Cardiovascular Risk With Testosterone Therapy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.